BEV-DG: Cross-Modal Learning under Bird's-Eye View for Domain Generalization of 3D Semantic Segmentation

Cross-modal Unsupervised Domain Adaptation (UDA) aims to exploit the complementarity of 2D-3D data to overcome the lack of annotation in a new domain. However, UDA methods rely on access to the target domain during training, meaning the trained model only works in a specific target domain. In light of this, we propose cross-modal learning under bird's-eye view for Domain Generalization (DG) of 3D semantic segmentation, called BEV-DG. DG is more challenging because the model cannot access the target domain during training, meaning it needs to rely on cross-modal learning to alleviate the domain gap. Since 3D semantic segmentation requires the classification of each point, existing cross-modal learning is directly conducted point-to-point, which is sensitive to the misalignment in projections between pixels and points. To this end, our approach aims to optimize domain-irrelevant representation modeling with the aid of cross-modal learning under bird's-eye view. We propose BEV-based Area-to-area Fusion (BAF) to conduct cross-modal learning under bird's-eye view, which has a higher fault tolerance for point-level misalignment. Furthermore, to model domain-irrelevant representations, we propose BEV-driven Domain Contrastive Learning (BDCL) with the help of cross-modal learning under bird's-eye view. We design three domain generalization settings based on three 3D datasets, and BEV-DG significantly outperforms state-of-the-art competitors with tremendous margins in all settings.Comment: Accepted by ICCV 202

A two-dimensional angular-resolved proton spectrometer

We present a novel design of two-dimensional (2D) angular-resolved spectrometer for full beam characterization of ultrashort intense laser driven proton sources. A rotated 2D pinhole array was employed, as selective entrance before a pair of parallel permanent magnets, to sample the full proton beam into discrete beamlets. The proton beamlets are subsequently dispersed without overlapping onto a planar detector. Representative experimental result of protons generated from femtosecond intense laser interaction with thin foil target is presented

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two

Background The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd. Methods We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background. Results First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001). Conclusions In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival

Systemic Immune Effects of Titanium Dioxide Nanoparticles after Repeated Intratracheal Instillation in Rat

The potential immune effects of titanium dioxide nanoparticles (nano-TiO2) are raising concern. Our previous study verified that nano-TiO2 induce local immune response in lung tissue followed by intratracheal instillation administration. In this study, we aim to evaluate the systemic immune effects of nano-TiO2. Sprague Dawley rats were treated by intratracheal instillation with nano-TiO2 at doses of 0.5, 4, and 32 mg/kg body weight, micro-TiO2 with 32 mg/kg body weight and 0.9% NaCl, respectively. The exposure was conducted twice a week, for four consecutive weeks. Histopathological immune organs from exposed animals showed slight congestion in spleen, generally brown particulate deposition in cervical and axillary lymph node. Furthermore, immune function response was characterized by increased proliferation of T cells and B cells following mitogen stimulation and enhanced natural killer (NK) cell killing activity in spleen, accompanying by increased number of B cells in blood. No significant changes of Th1-type cytokines (IL-2 and INF-γ) and Th2-type cytokines (TNF-α and IL-6) were observed. Intratracheal exposure to nano-TiO2 may be one of triggers to be responsible for the systemic immune response. Further study is needed to confirm long-lasting lymphocyte responses and the potential mechanisms